Yingying Wang

Researcher

UAMS

Also affiliated: Anhui University (2011–2021); University of Shanghai for Science and Technology (2019); Chinese Academy of Medical Sciences & Peking Union Medical College (2017); Nankai University (2013); Fudan University (2019); Beijing Normal University (2014–2017); Naval Aeronautical and Astronautical University (2020); Jining Medical University (2022); Southeast University (2008); University of Hong Kong (2004)

Faculty Researcher

8 h-index 24 pubs 764 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website

OverviewAI-generated summary

Yingying Wang's research focuses on developing novel senolytic compounds, agents designed to selectively eliminate senescent cells, which are implicated in various age-related diseases. Her work has involved the design and optimization of piperlongumine analogs as potent senolytics. Additionally, Wang has investigated the in vitro activity of Vernonia cumingiana Benth. Her publications also extend to materials science, including work on enhancing the thermal and mechanical properties of polymethyl methacrylate (PMMA)/graphene nanoplatelets (GNPs) nanocomposites for electronic component radiators, and improving the thermally conductive and microwave absorbing properties of PMMA/Ni@GNP nanocomposites. Wang holds a h-index of 8 with 24 publications and 753 citations.

Metrics

h-index: 8
Publications: 24
Citations: 764

Selected Publications

Design and optimization of piperlongumine analogs as potent senolytics (2023)

Bioorganic & Medicinal Chemistry Letters 4 citations DOI OpenAlex
Inhibition of Bcl-2/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice (2017)

International Journal of Radiation Oncology*Biology*Physics 243 citations DOI OpenAlex